Kaufmann Hitto 4
4 · PIERIS PHARMACEUTICALS, INC. · Filed Sep 3, 2019
Insider Transaction Report
Form 4
Kaufmann Hitto
SVP, Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2019-08-30+300,000→ 300,000 totalExercise: $4.65Exp: 2029-08-30→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the option shares on August 30, 2020 and vests as to an additional 6.25% of the option shares at the end of each successive calendar quarter thereafter beginning on December 31, 2020.